UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000051527
Receipt number R000058774
Scientific Title In vivo and ex vivo microcirculation assessment in cardiac rehabilitation
Date of disclosure of the study information 2023/07/10
Last modified on 2024/11/13 12:00:26

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Verification of the Effect of Rehabilitation on Microcirculation in Patients with Cardiac Disease - An Observational Study -

Acronym

Verification of the Effect of Rehabilitation on Microcirculation in Patients with Cardiac Disease - An Observational Study -

Scientific Title

In vivo and ex vivo microcirculation assessment in cardiac rehabilitation

Scientific Title:Acronym

In vivo and ex vivo microcirculation assessment in cardiac rehabilitation

Region

Japan


Condition

Condition

cardiovascular disease

Classification by specialty

Cardiology Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To clarify the effects of 3 months of cardiac rehabilitation on finger nail bed microcirculation and blood fluidity in patients with cardiovascular diseases

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Changes in finger nail bed microcirculation after 3 months of cardiac rehabilitation

Key secondary outcomes

Patient background,Cardiovascular test,Blood test,Blood fluidity test,Blood adhesion test,Sarcopenia evaluation,Physical evaluation,Expiratory gas test,Autonomic nerve test,Event survey


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Patients who are hospitalized at Dokkyo Medical University Nikko Medical Center and are prescribed cardiovascular rehabilitation
2)Patients aged 18 years or older at the time of informed consent
3)Patients who gave their written informed consent to participate in the study

Key exclusion criteria

1) Patients who are judged inappropriate for study participation by the attending physician
2) Patients who have difficulty walking

Target sample size

220


Research contact person

Name of lead principal investigator

1st name Takanori
Middle name
Last name Yasu

Organization

Dokkyo Medical University Nikko Medical Center

Division name

Department of Cardiovasular Medicine and Nephrology

Zip code

3211298

Address

145-1 Moritomo, Nikko City, Tochigi Prefecture

TEL

0288237000

Email

t-masato@dokkyomed.ac.jp


Public contact

Name of contact person

1st name Masato
Middle name
Last name Terashima

Organization

Dokkyo Medical University Nikko Medical Center

Division name

Department of Rehabilitation

Zip code

3211298

Address

145-1 Moritomo, Nikko City, Tochigi Prefecture

TEL

0288237000

Homepage URL


Email

t-masato@dokkyomed.ac.jp


Sponsor or person

Institute

Dokkyo Medical University Nikko Medical Center

Institute

Department

Personal name



Funding Source

Organization

Dokkyo International Medical Education and Research Foundation

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Dokkyo Medical University Nikko Medical Center Bioethics Committee

Address

145-1 Moritomo, Nikko City, Tochigi Prefecture

Tel

0288237000

Email

rinshokenkyu@dokkyomed.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 07 Month 10 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2021 Year 10 Month 28 Day

Date of IRB

2021 Year 11 Month 11 Day

Anticipated trial start date

2021 Year 11 Month 11 Day

Last follow-up date

2030 Year 12 Month 31 Day

Date of closure to data entry

2031 Year 03 Month 31 Day

Date trial data considered complete

2031 Year 05 Month 31 Day

Date analysis concluded

2031 Year 07 Month 31 Day


Other

Other related information

Study design
Single center prospective observational study
Recruitment method
All patients admitted to Dokkyo Medical University Nikko Medical Center from November 11 2021 to December 31 2030 who meet the selection criteria
Measurement item
Baseline survey Visit 1
Age gender
Rehabilitation calculation disease
medical history
Coronary risk factors
NYHA classification
Height Weight BMI
Blood pressure Pulse
Blood test
In vivo evaluation of subungual microcirculation
Prescription drug information
Blood fluidity test
Echocardiography
ABI
FMD
Sarcopenia evaluation
Body evaluation
Breath gas test
Autonomic nerve test
Evaluation of blood viscosity in macro and micro vessels

Investigation 3 months after discharge Visit 2
NYHA classification
Weight BMI
Blood pressure Pulse
Blood test
Prescription drug information
In vivo evaluation of subungual microcirculation
Blood fluidity test
Echocardiography
Sarcopenia evaluation
Body evaluation
Breath gas test
Autonomic nerve test
Event research
Evaluation of blood viscosity in macro and micro vessels

Follow-up survey until the end of the study period Conducted every year from the time of discharge
Weight BMI
Blood pressure Ppulse
Blood test
Event research


Management information

Registered date

2023 Year 07 Month 05 Day

Last modified on

2024 Year 11 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000058774